Last Posted: Nov 21, 2019
- Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
Hellmann Matthew D et al. The New England journal of medicine 2019 Nov (21) 2020-2031 - Transplantation as disease modifying therapy in adults with inherited metabolic disorders.
Sirrs Sandra et al. Journal of inherited metabolic disease 2018 41(5) 885-896 - Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology.
Bartha Áron et al. Cancers 2019 Nov 11(11) - Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
D Chowell et al, Nature Medicine, November 7, 2019 - CRISPR Approach To Fighting Cancer Called 'Promising' In 1st Safety Test
R Stein, NPR, November 6, 2019 - Crispr Takes Its First Steps in Editing Genes to Fight Cancer
D Grady, NY Times, November 6, 2019 - Doctors try CRISPR gene editing for cancer, a 1st in the US
M Marchione, Washington Post, November 6, 2019 - A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab.
Friedlander Philip et al. Journal for immunotherapy of cancer 2018 6(1) 90 - NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
Ettinger David S et al. Journal of the National Comprehensive Cancer Network : JNCCN 2018 16(7) 807-821 - Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death.
Kulkarni Prathamesh M et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Oct
.png)
No hay comentarios:
Publicar un comentario